These additions do not undermine weight loss because even with them, most patients on GLP-1 therapy still maintain a significant caloric deficit
Pancreatic histopathology can confirm changes consistent with islet cell neoplasia and beta cell hyperproliferation, with staining for insulin, glucagon, and somatostatin
NielsenIQ segments new consumers who have started taking the medication in the latest 1-3 months, 4-6 months, and 7-11 months, and interestingly, in the latest 1-3 month data set, the newest users index even younger
Psychiatric safety of semaglutide for weight management in people without known major psychopathology: post hoc analysis of the STEP 1, 2, 3, and 5 trials